Bariatric Surgery and Gut-Brain-Axis Driven Alterations in Cognition and Inflammation

References

• Fruh SM. Obesity: risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017;29(S1):S3–S14. doi:10.1002/2327-6924.12510
   PubMedGoogle Scholar
• World Health Organization. Fact sheet: obesity and overweight; 2021.
   Google Scholar
• Nota MHC, Vreeken D, Wiesmann M, Aarts EO, Hazebroek EJ, Kiliaan AJ. Obesity affects brain structure and function- rescue by bariatric surgery? Neurosci Biobehav Rev. 2020;108:646–657. doi:10.1016/j.neubiorev.2019.11.025
   PubMed Web of Science ®Google Scholar
• Dekkers IA, Jansen PR, Lamb HJ. Obesity, brain volume, and white matter microstructure at MRI: a cross-sectional UK Biobank Study. Radiology. 2019;291(3):763–771. doi:10.1148/radiol.2019181012
   PubMed Web of Science ®Google Scholar
• Verstynen TD, Weinstein AM, Schneider WW, Jakicic JM, Rofey DL, Erickson KI. Increased body mass index is associated with a global and distributed decrease in white matter microstructural integrity. Psychosom Med. 2012;74(7):682–690. doi:10.1097/PSY.0b013e318261909c
   PubMed Web of Science ®Google Scholar
• Lampe L, Zhang R, Beyer F, et al. Visceral obesity relates to deep white matter hyperintensities via inflammation. Ann Neurol. 2019;85(2):194–203. doi:10.1002/ana.25396
   PubMed Web of Science ®Google Scholar
• Shaw ME, Sachdev PS, Abhayaratna W, Anstey KJ, Cherbuin N. Body mass index is associated with cortical thinning with different patterns in mid- and late-life. Int J Obesity. 2018;42(3):455–461. doi:10.1038/ijo.2017.254
   Web of Science ®Google Scholar
• Arnoldussen IAC, Wiesmann M, Pelgrim CE, et al. Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice. Int J Obes. 2017;41(6):935–944. doi:10.1038/ijo.2017.52
   Web of Science ®Google Scholar
• Forny-Germano L, De Felice FG, Vieira M. The role of leptin and adiponectin in obesity-associated cognitive decline and Alzheimer’s disease. Front Neurosci. 2018;12:1027. doi:10.3389/fnins.2018.01027
   PubMed Web of Science ®Google Scholar
• Dionysopoulou S, Charmandari E, Bargiota A, Vlahos N, Mastorakos G, Valsamakis G. The role of hypothalamic inflammation in diet-induced obesity and its association with cognitive and mood disorders. Nutrients. 2021;13(2):498. doi:10.3390/nu13020498
   PubMed Web of Science ®Google Scholar
• Vreeken D, Seidel F, Custers EM, et al. Factors associated with cognitive improvement after bariatric surgery among patients with severe obesity in the Netherlands. JAMA Netw Open. 2023;6(5):e2315936. doi:10.1001/jamanetworkopen.2023.15936
   PubMed Web of Science ®Google Scholar
• Brinkworth GD, Buckley JD, Noakes M, Clifton PM, Wilson CJ. Long-term effects of a very low-carbohydrate diet and a low-fat diet on mood and cognitive function. Arch Intern Med. 2009;169(20):1873–1880. doi:10.1001/archinternmed.2009.329
   PubMedGoogle Scholar
• Horie NC, Serrao VT, Simon SS, et al. Cognitive effects of intentional weight loss in elderly obese individuals with mild cognitive impairment. J Clin Endocrinol Metab. 2016;101(3):1104–1112. doi:10.1210/jc.2015-2315
   PubMed Web of Science ®Google Scholar
• Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255–2263. doi:10.1016/S0140-6736(15)60461-5
   PubMed Web of Science ®Google Scholar
• Varkevisser RDM, van Stralen MM, Kroeze W, Ket JCF, Steenhuis IHM. Determinants of weight loss maintenance: a systematic review. Obes Rev. 2019;20(2):171–211. doi:10.1111/obr.12772
   PubMed Web of Science ®Google Scholar
• Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879–887. doi:10.1001/jama.2020.12567
   PubMed Web of Science ®Google Scholar
• Nuzzo A, Czernichow S, Hertig A, et al. Prevention and treatment of nutritional complications after bariatric surgery. Lancet Gastroenterol Hepatol. 2021;6(3):238–251. doi:10.1016/S2468-1253(20)30331-9
   PubMed Web of Science ®Google Scholar
• Courcoulas AP, Yanovski SZ, Bonds D, et al. Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. JAMA Surg. 2014;149(12):1323–1329. doi:10.1001/jamasurg.2014.2440
   PubMed Web of Science ®Google Scholar
• Cummings DE, Cohen RV. Bariatric/metabolic surgery to treat type 2 diabetes in patients with a BMI <35 kg/m2. Diabetes Care. 2016;39(6):924–933. doi:10.2337/dc16-0350
   PubMed Web of Science ®Google Scholar
• Schauer DP, Feigelson HS, Koebnick C, et al. Association between weight loss and the risk of cancer after bariatric surgery. Obesity. 2017;25(Suppl 2):S52–S57. doi:10.1002/oby.22002
   PubMedGoogle Scholar
• Morris A. Life expectancy: benefits of bariatric surgery clarified. Nat Rev Endocrinol. 2021;17(1):4–5. doi:10.1038/s41574-020-00440-7
   PubMed Web of Science ®Google Scholar
• Syn NL, Cummings DE, Wang LZ, et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. Lancet. 2021;397(10287):1830–1841. doi:10.1016/S0140-6736(21)00591-2
   PubMed Web of Science ®Google Scholar
• Martinou E, Stefanova I, Iosif E, Angelidi AM. Neurohormonal changes in the gut-brain axis and underlying neuroendocrine mechanisms following bariatric surgery. Int J Mol Sci. 2022;23(6):3339. doi:10.3390/ijms23063339
   PubMed Web of Science ®Google Scholar
• Cryan JF, O’Riordan KJ, Cowan CSM, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877–2013. doi:10.1152/physrev.00018.2018
   PubMed Web of Science ®Google Scholar
• Alvarez Bartolomé M, Borque M, Martinez-Sarmiento J, et al. Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty. Obes Surg. 2002;12(3):324–327. doi:10.1381/096089202321088084
   PubMed Web of Science ®Google Scholar
• De Michele M, Panico S, Iannuzzi A, et al. Association of obesity and central fat distribution with carotid artery wall thickening in middle-aged women. Stroke. 2002;33(12):2923–2928. doi:10.1161/01.STR.0000038989.90931.BE
   PubMed Web of Science ®Google Scholar
• Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349(10):941–948. doi:10.1056/NEJMoa030204
   PubMed Web of Science ®Google Scholar
• Frühbeck G, Diez-Caballero A, Gil MJ, et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg. 2004;14(5):606–612. doi:10.1381/096089204323093363
   PubMed Web of Science ®Google Scholar
• Stoeckli R, Chanda R, Langer I, Keller U. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res. 2004;12(2):346–350. doi:10.1038/oby.2004.43
   PubMedGoogle Scholar
• Garcia-Fuentes E, Garrido-Sanchez L, Garcia-Almeida JM, et al. Different effect of laparoscopic Roux-en-Y gastric bypass and open biliopancreatic diversion of Scopinaro on serum PYY and ghrelin levels. Obes Surg. 2008;18(11):1424–1429. doi:10.1007/s11695-008-9560-5
   PubMed Web of Science ®Google Scholar
• Batterham RL, Heffron H, Kapoor S, et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 2006;4(3):223–233. doi:10.1016/j.cmet.2006.08.001
   PubMed Web of Science ®Google Scholar
• Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247(3):401–407. doi:10.1097/SLA.0b013e318156f012
   PubMed Web of Science ®Google Scholar
• Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106(7):2365–2370. doi:10.1073/pnas.0812600106
   PubMed Web of Science ®Google Scholar
• Rigamonti AE, Resnik M, Compri E, et al. The cholestyramine-induced decrease of PYY postprandial response is negatively correlated with fat mass in obese women. Horm Metab Res. 2011;43(8):569–573. doi:10.1055/s-0031-1280783
   PubMed Web of Science ®Google Scholar
• Salehi M, Prigeon RL, D’Alessio DA. Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes. 2011;60(9):2308–2314. doi:10.2337/db11-0203
   PubMed Web of Science ®Google Scholar
• Dar MS, Chapman WH, Pender JR, et al. GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)? Obes Surg. 2012;22(7):1077–1083. doi:10.1007/s11695-012-0624-1
   PubMed Web of Science ®Google Scholar
• Peterli R, Steinert RE, Woelnerhanssen B, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22(5):740–748. doi:10.1007/s11695-012-0622-3
   PubMed Web of Science ®Google Scholar
• Ramón JM, Salvans S, Crous X, et al. Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial. J Gastrointest Surg. 2012;16(6):1116–1122. doi:10.1007/s11605-012-1855-0
   PubMed Web of Science ®Google Scholar
• Tschoner A, Sturm W, Engl J, et al. Plasminogen activator inhibitor 1 and visceral obesity during pronounced weight loss after bariatric surgery. Nutr, Metab Cardiovasc Dis. 2012;22(4):340–346. doi:10.1016/j.numecd.2010.07.009
   PubMed Web of Science ®Google Scholar
• Barazzoni R, Zanetti M, Nagliati C, et al. Gastric bypass does not normalize obesity-related changes in ghrelin profile and leads to higher acylated ghrelin fraction. Obesity. 2013;21(4):718–722. doi:10.1002/oby.20272
   PubMed Web of Science ®Google Scholar
• Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F, Mingrone G. Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects. Ann Surg. 2013;257(3):462–468. doi:10.1097/SLA.0b013e318269cf5c
   PubMed Web of Science ®Google Scholar
• Tsoli M, Chronaiou A, Kehagias I, Kalfarentzos F, Alexandrides TK. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study. Surg Obes Relat Dis. 2013;9(5):667–677. doi:10.1016/j.soard.2012.12.006
   PubMed Web of Science ®Google Scholar
• Verdam FJ, Fuentes S, de Jonge C, et al. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity. 2013;21(12):E607–E15. doi:10.1002/oby.20466
   PubMed Web of Science ®Google Scholar
• Cahill F, Ji Y, Wadden D, et al. The Association of Serum Total Peptide YY (PYY) with obesity and body fat measures in the CODING Study. PLoS One. 2014;9(4):e95235. doi:10.1371/journal.pone.0095235
   PubMed Web of Science ®Google Scholar
• Yousseif A, Emmanuel J, Karra E, et al. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes Surg. 2014;24(2):241–252. doi:10.1007/s11695-013-1066-0
   PubMed Web of Science ®Google Scholar
• Cheke LG, Bonnici HM, Clayton NS, Simons JS. Obesity and insulin resistance are associated with reduced activity in core memory regions of the brain. Neuropsychologia. 2017;96:137–149. doi:10.1016/j.neuropsychologia.2017.01.013
   PubMed Web of Science ®Google Scholar
• Bove RM, Gerweck AV, Mancuso SM, Bredella MA, Sherman JC, Miller KK. Association between adiposity and cognitive function in young men: hormonal mechanisms. Obesity. 2016;24(4):954–961. doi:10.1002/oby.21415
   PubMed Web of Science ®Google Scholar
• Kruljac I, Mirošević G, Kirigin LS, et al. Changes in metabolic hormones after bariatric surgery and their predictive impact on weight loss. Clin Endocrinol. 2016;85(6):852–860. doi:10.1111/cen.13160
   PubMed Web of Science ®Google Scholar
• Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med. 2016;8(1):67. doi:10.1186/s13073-016-0312-1
   PubMed Web of Science ®Google Scholar
• Barczynska R, Litwin M, Slizewska K, et al. Bacterial microbiota and fatty acids in the faeces of overweight and obese children. Pol J Microbiol. 2018;67(3):339–345. doi:10.21307/pjm-2018-041
   PubMed Web of Science ®Google Scholar
• Krumbeck JA, Rasmussen HE, Hutkins RW, et al. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Microbiome. 2018;6(1):121. doi:10.1186/s40168-018-0494-4
   PubMed Web of Science ®Google Scholar
• Dao MC, Belda E, Prifti E, et al. Akkermansia muciniphila abundance is lower in severe obesity, but its increased level after bariatric surgery is not associated with metabolic health improvement. Am J Physiol Endocrinol Metab. 2019;317(3):E446–E459. doi:10.1152/ajpendo.00140.2019
   PubMed Web of Science ®Google Scholar
• Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096–1103. doi:10.1038/s41591-019-0495-2
   PubMed Web of Science ®Google Scholar
• Guida C, Stephen SD, Watson M, et al. PYY plays a key role in the resolution of diabetes following bariatric surgery in humans. EBioMedicine. 2019;40:67–76. doi:10.1016/j.ebiom.2018.12.040
   PubMed Web of Science ®Google Scholar
• Huang T, Chen Z, Shen L, Fan X, Wang K. Associations of cognitive function with BMI, body fat mass and visceral fat in young adulthood. Medicina. 2019;55(6):221. doi:10.3390/medicina55060221
   PubMedGoogle Scholar
• Hui SCN, Wong SKH, Ai Q, Yeung DKW, Ng EK, Chu WCW. Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: evaluation with MRI. Eur Radiol. 2019;29(2):849–856. doi:10.1007/s00330-018-5611-z
   PubMed Web of Science ®Google Scholar
• Maïmoun L, Lefebvre P, Aouinti S, Picot MC, Mariano-Goulart D, Nocca D. Acute and longer-term body composition changes after bariatric surgery. Surg Obes Relat Dis. 2019;15(11):1965–1973.
   PubMed Web of Science ®Google Scholar
• Marseglia A, Fratiglioni L, Kalpouzos G, Wang R, Bäckman L, Xu W. Prediabetes and diabetes accelerate cognitive decline and predict microvascular lesions: a population-based cohort study. Alzheimers Dement. 2019;15(1):25–33. doi:10.1016/j.jalz.2018.06.3060
   PubMed Web of Science ®Google Scholar
• Perakakis N, Kokkinos A, Peradze N, et al. Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: evidence from two independent trials. Metabolism. 2019;101:153997. doi:10.1016/j.metabol.2019.153997
   PubMed Web of Science ®Google Scholar
• Svane MS, Bojsen-Møller KN, Martinussen C, et al. Postprandial nutrient handling and gastrointestinal hormone secretion after Roux-en-Y gastric bypass vs sleeve gastrectomy. Gastroenterology. 2019;156(6):1627–41.e1. doi:10.1053/j.gastro.2019.01.262
   PubMed Web of Science ®Google Scholar
• Tsouristakis AI, Febres G, McMahon DJ, et al. Long-term modulation of appetitive hormones and sweet cravings after adjustable gastric banding and Roux-en-Y gastric bypass. Obes Surg. 2019;29(11):3698–3705. doi:10.1007/s11695-019-04111-z
   PubMed Web of Science ®Google Scholar
• Lopez-Nava G, Negi A, Bautista-Castaño I, Rubio MA, Asokkumar R. Gut and metabolic hormones changes after Endoscopic Sleeve Gastroplasty (ESG) vs Laparoscopic Sleeve Gastrectomy (LSG). Obes Surg. 2020;30(7):2642–2651. doi:10.1007/s11695-020-04541-0
   PubMed Web of Science ®Google Scholar
• Han K, Singh K, Rodman MJ, et al. Identification and validation of nutrient state-dependent serum protein mediators of human CD4(+) T cell responsiveness. Nutrients. 2021;13(5):1492. doi:10.3390/nu13051492
   PubMed Web of Science ®Google Scholar
• Kanazawa A, Aida M, Yoshida Y, et al. Effects of synbiotic supplementation on chronic inflammation and the gut microbiota in obese patients with type 2 diabetes mellitus: a randomized controlled study. Nutrients. 2021;13(2):558. doi:10.3390/nu13020558
   PubMed Web of Science ®Google Scholar
• Leyrolle Q, Cserjesi R, Dghm M, et al. Prebiotic effect on mood in obese patients is determined by the initial gut microbiota composition: a randomized, controlled trial. Brain Behav Immun. 2021;94:289–298. doi:10.1016/j.bbi.2021.01.014
   PubMed Web of Science ®Google Scholar
• Martínez-Cuesta MC, Del Campo R, Garriga-García M, Peláez C, Requena T. Taxonomic characterization and short-chain fatty acids production of the obese microbiota. Front Cell Infect Microbiol. 2021;11:598093. doi:10.3389/fcimb.2021.598093
   PubMed Web of Science ®Google Scholar
• Agarwal K, Maki KA, Vizioli C, et al. The neuro-endo-microbio-ome study: a pilot study of neurobiological alterations pre- versus post-bariatric surgery. Biol. Res. Nurs. 2022;24(3):362–378. doi:10.1177/10998004221085976
   PubMed Web of Science ®Google Scholar
• Lejawa M, Osadnik K, Czuba Z, Osadnik T, Pawlas N. Association of metabolically healthy and unhealthy obesity phenotype with markers related to obesity, diabetes among young, healthy adult men. Analysis of MAGNETIC Study. Life. 2021;11(12):1350. doi:10.3390/life11121350
   PubMedGoogle Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–1031. doi:10.1038/nature05414
   PubMed Web of Science ®Google Scholar
• Briggs DI, Enriori PJ, Lemus MB, Cowley MA, Andrews ZB. Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology. 2010;151(10):4745–4755. doi:10.1210/en.2010-0556
   PubMed Web of Science ®Google Scholar
• Porter DW, Kerr BD, Flatt PR, Holscher C, Gault VA. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance. Diabetes Obes Metab. 2010;12(10):891–899. doi:10.1111/j.1463-1326.2010.01259.x
   PubMed Web of Science ®Google Scholar
• Pratchayasakul W, Kerdphoo S, Petsophonsakul P, Pongchaidecha A, Chattipakorn N, Chattipakorn SC. Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone. Life Sci. 2011;88(13–14):619–627. doi:10.1016/j.lfs.2011.02.003
   PubMed Web of Science ®Google Scholar
• Lam YY, Ha CW, Campbell CR, et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One. 2012;7(3):e34233. doi:10.1371/journal.pone.0034233
   PubMed Web of Science ®Google Scholar
• Lee YS, Park MS, Choung JS, et al. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia. 2012;55(9):2456–2468. doi:10.1007/s00125-012-2592-3
   PubMed Web of Science ®Google Scholar
• Kappe C, Tracy LM, Patrone C, Iverfeldt K, Sjöholm Å. GLP-1 secretion by microglial cells and decreased CNS expression in obesity. J Neuroinflammation. 2012;9(1):276. doi:10.1186/1742-2094-9-276
   PubMedGoogle Scholar
• Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110(22):9066–9071. doi:10.1073/pnas.1219451110
   PubMed Web of Science ®Google Scholar
• Liou AP, Paziuk M, Luevano JM, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5(178):178ra41. doi:10.1126/scitranslmed.3005687
   PubMed Web of Science ®Google Scholar
• Porter WD, Flatt PR, Hölscher C, Gault VA. Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice. Int J Obes. 2013;37(5):678–684. doi:10.1038/ijo.2012.91
   Web of Science ®Google Scholar
• Lennox R, Porter DW, Flatt PR, Holscher C, Irwin N, Gault VA. Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice. Neuropharmacology. 2014;86:22–30. doi:10.1016/j.neuropharm.2014.06.026
   PubMed Web of Science ®Google Scholar
• Pintana H, Sripetchwandee J, Supakul L, Apaijai N, Chattipakorn N, Chattipakorn S. Garlic extract attenuates brain mitochondrial dysfunction and cognitive deficit in obese-insulin resistant rats. Appl Physiol Nutr Metab. 2014;39(12):1373–1379. doi:10.1139/apnm-2014-0255
   PubMed Web of Science ®Google Scholar
• Uchida A, Zechner JF, Mani BK, Park WM, Aguirre V, Zigman JM. Altered ghrelin secretion in mice in response to diet-induced obesity and Roux-en-Y gastric bypass. Mol Metab. 2014;3(7):717–730. doi:10.1016/j.molmet.2014.07.009
   PubMed Web of Science ®Google Scholar
• Hamilton MK, Boudry G, Lemay DG, Raybould HE. Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am J Physiol Gastrointest Liver Physiol. 2015;308(10):G840–G851. doi:10.1152/ajpgi.00029.2015
   PubMed Web of Science ®Google Scholar
• Naznin F, Toshinai K, Waise TM, et al. Diet-induced obesity causes peripheral and central ghrelin resistance by promoting inflammation. J Endocrinol. 2015;226(1):81–92. doi:10.1530/JOE-15-0139
   PubMed Web of Science ®Google Scholar
• Waise TMZ, Toshinai K, Naznin F, et al. One-day high-fat diet induces inflammation in the nodose ganglion and hypothalamus of mice. Biochem Biophys Res Commun. 2015;464(4):1157–1162. doi:10.1016/j.bbrc.2015.07.097
   PubMed Web of Science ®Google Scholar
• Yan M, Song MM, Bai RX, Cheng S, Yan WM. Effect of Roux-en-Y gastric bypass surgery on intestinal Akkermansia muciniphila. World J Gastrointest Surg. 2016;8(4):301–307. doi:10.4240/wjgs.v8.i4.301
   PubMedGoogle Scholar
• Sa-Nguanmoo P, Tanajak P, Kerdphoo S, et al. SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats. Toxicol Appl Pharmacol. 2017;333:43–50. doi:10.1016/j.taap.2017.08.005
   PubMed Web of Science ®Google Scholar
• Pétrault O, Pétrault M, Ouk T, Bordet R, Bérézowski V, Bastide M. Visceral adiposity links cerebrovascular dysfunction to cognitive impairment in middle-aged mice. Neurobiol Dis. 2019;130:104536. doi:10.1016/j.nbd.2019.104536
   PubMed Web of Science ®Google Scholar
• Zhang P, Yu Y, Qin Y, et al. Alterations to the microbiota-colon-brain axis in high-fat-diet-induced obese mice compared to diet-resistant mice. J Nutr Biochem. 2019;65:54–65. doi:10.1016/j.jnutbio.2018.08.016
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang T, Hu J, et al. Adiponectin/SIRT1 axis induces white adipose browning after vertical sleeve gastrectomy of obese rats with type 2 diabetes. Obes Surg. 2020;30(4):1392–1403. doi:10.1007/s11695-019-04295-4
   PubMed Web of Science ®Google Scholar
• Liu Z, Li L, Ma S, et al. High-dietary fiber intake alleviates antenatal obesity-induced postpartum depression: roles of gut microbiota and microbial metabolite short-chain fatty acid involved. J Agric Food Chem. 2020;68(47):13697–13710. doi:10.1021/acs.jafc.0c04290
   PubMed Web of Science ®Google Scholar
• Liu Z, Dai X, Zhang H, et al. Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment. Nat Commun. 2020;11(1):855. doi:10.1038/s41467-020-14676-4
   PubMed Web of Science ®Google Scholar
• Shi H, Wang Q, Zheng M, et al. Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice. J Neuroinflammation. 2020;17(1):77. doi:10.1186/s12974-020-01760-1
   PubMed Web of Science ®Google Scholar
• Doncheva AI, Norheim FA, Hjorth M, et al. Serglycin is involved in adipose tissue inflammation in obesity. J Immunol. 2022;208(1):121–132. doi:10.4049/jimmunol.2100231
   PubMed Web of Science ®Google Scholar
• Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273(5277):974–977. doi:10.1126/science.273.5277.974
   PubMed Web of Science ®Google Scholar
• Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50(4):707–709. doi:10.2337/diabetes.50.4.707
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A. 2004;101(13):4679–4684. doi:10.1073/pnas.0305930101
   PubMed Web of Science ®Google Scholar
• Mani BK, Walker AK, Lopez Soto EJ, et al. Neuroanatomical characterization of a growth hormone secretagogue receptor-green fluorescent protein reporter mouse. J Comp Neurol. 2014;522(16):3644–3666. doi:10.1002/cne.23627
   PubMed Web of Science ®Google Scholar
• Date Y. Ghrelin and the vagus nerve. Methods Enzymol. 2012;514:261–269.
   PubMed Web of Science ®Google Scholar
• Banks WA, Burney BO, Robinson SM. Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier. Peptides. 2008;29(11):2061–2065. doi:10.1016/j.peptides.2008.07.001
   PubMed Web of Science ®Google Scholar
• Gardiner JV, Campbell D, Patterson M, et al. The hyperphagic effect of ghrelin is inhibited in mice by a diet high in fat. Gastroenterology. 2010;138(7):2468–76, 76.e1.
   PubMed Web of Science ®Google Scholar
• Perreault M, Istrate N, Wang L, Nichols AJ, Tozzo E, Stricker-Krongrad A. Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss. Int J Obes Relat Metab Disord. 2004;28(7):879–885. doi:10.1038/sj.ijo.0802640
   PubMed Web of Science ®Google Scholar
• English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JP. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab. 2002;87(6):2984. doi:10.1210/jcem.87.6.8738
   PubMed Web of Science ®Google Scholar
• Seminara RS, Jeet C, Biswas S, et al. The neurocognitive effects of ghrelin-induced signaling on the hippocampus: a promising approach to Alzheimer’s disease. Cureus. 2018;10(9):e3285.
   PubMed Web of Science ®Google Scholar
• Perea Vega ML, Sanchez MS, Fernández G, Paglini MG, Martin M, de Barioglio SR. Ghrelin treatment leads to dendritic spine remodeling in hippocampal neurons and increases the expression of specific BDNF-mRNA species. Neurobiol Learn Mem. 2021;179:107409. doi:10.1016/j.nlm.2021.107409
   PubMed Web of Science ®Google Scholar
• Edwards CM, Dolezel T, Rinaman L. Ghrelin receptor signaling contributes to fasting-induced suppression of conditioned avoidance behavior and neural circuit activation in male rats. bioRxiv. 2022. doi:10.1101/2022.02.11.480168
   Google Scholar
• Spitznagel MB, Benitez A, Updegraff J, et al. Serum ghrelin is inversely associated with cognitive function in a sample of non-demented elderly. Psychiat Clin Neuros. 2010;64(6):608–611. doi:10.1111/j.1440-1819.2010.02145.x
   PubMed Web of Science ®Google Scholar
• Tesauro M, Schinzari F, Iantorno M, et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation. 2005;112(19):2986–2992. doi:10.1161/CIRCULATIONAHA.105.553883
   PubMed Web of Science ®Google Scholar
• Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004;114(1):57–66. doi:10.1172/JCI200421134
   PubMed Web of Science ®Google Scholar
• Naznin F, Toshinai K, Waise TMZ, Okada T, Sakoda H, Nakazato M. Restoration of metabolic inflammation-related ghrelin resistance by weight loss. J Mol Endocrinol. 2018;60(2):109–118. doi:10.1530/JME-17-0192
   PubMed Web of Science ®Google Scholar
• Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50(8):1714–1719. doi:10.2337/diabetes.50.8.1714
   PubMed Web of Science ®Google Scholar
• García-Unzueta MT, Fernández-Santiago R, Domínguez-Díez A, Vazquez-Salví L, Fernández-Escalante JC, Amado JA. Fasting plasma ghrelin levels increase progressively after biliopancreatic diversion: one-year follow-up. Obes Surg. 2005;15(2):187–190. doi:10.1381/0960892053268453
   PubMed Web of Science ®Google Scholar
• Ojha A, Ojha U, Mohammed R, Chandrashekar A, Ojha H. Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus. Clin Pharmacol. 2019;11:57–65. doi:10.2147/CPAA.S202614
   PubMed Web of Science ®Google Scholar
• Fu Z, Gilbert ER, Liu D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev. 2013;9(1):25–53. doi:10.2174/157339913804143225
   PubMedGoogle Scholar
• Erichsen JM, Fadel JR, Reagan LP. Peripheral versus central insulin and leptin resistance: role in metabolic disorders, cognition, and neuropsychiatric diseases. Neuropharmacology. 2022;203:108877. doi:10.1016/j.neuropharm.2021.108877
   PubMed Web of Science ®Google Scholar
• Sripetchwandee J, Chattipakorn N, Chattipakorn SC. Links between obesity-induced brain insulin resistance, brain mitochondrial dysfunction, and dementia. Front Endocrinol. 2018;9:496. doi:10.3389/fendo.2018.00496
   PubMed Web of Science ®Google Scholar
• Garber AJ. Incretin effects on β-cell function, replication, and mass: the human perspective. Diabetes Care. 2011;34(Suppl 2):S258–S263. doi:10.2337/dc11-s230
   PubMedGoogle Scholar
• Palta P, Schneider AL, Biessels GJ, Touradji P, Hill-Briggs F. Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc. 2014;20(3):278–291. doi:10.1017/S1355617713001483
   PubMed Web of Science ®Google Scholar
• Sivitz WI, Wayson SM, Bayless ML, Sinkey CA, Haynes WG. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes. J Diabetes Complicat. 2007;21(3):149–157. doi:10.1016/j.jdiacomp.2005.12.003
   PubMed Web of Science ®Google Scholar
• Hughes TM, Ryan CM, Aizenstein HJ, et al. Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications. J Diabetes Complicat. 2013;27(6):558–564. doi:10.1016/j.jdiacomp.2013.07.001
   PubMed Web of Science ®Google Scholar
• Hsu JL, Chen YL, Leu JG, et al. Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study. Neuroimage. 2012;59(2):1098–1105. doi:10.1016/j.neuroimage.2011.09.041
   PubMed Web of Science ®Google Scholar
• Ennis GE, Saelzler U, Umpierrez GE, Moffat SD. Prediabetes and working memory in older adults. Brain Neurosci Adv. 2020;4:2398212820961725. doi:10.1177/2398212820961725
   Google Scholar
• Liang M, Cai X, Tang Y, et al. Diffusion tensor imaging of white matter in patients with prediabetes by trace-based spatial statistics. J Magn Reson Imaging. 2019;49(4):1105–1112. doi:10.1002/jmri.26290
   PubMed Web of Science ®Google Scholar
• Willmann C, Brockmann K, Wagner R, et al. Insulin sensitivity predicts cognitive decline in individuals with prediabetes. BMJ Open Diabetes Res Care. 2020;8(2):e001741. doi:10.1136/bmjdrc-2020-001741
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Blomgren K, Kroemer G. Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci. 2009;10(7):481–494. doi:10.1038/nrn2665
   PubMed Web of Science ®Google Scholar
• Simpson DSA, Oliver PL. ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease. Antioxidants. 2020;9(8):743. doi:10.3390/antiox9080743
   Web of Science ®Google Scholar
• Zhang J, Wang X, Vikash V, et al. ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev. 2016;2016:4350965. doi:10.1155/2016/4350965
   PubMed Web of Science ®Google Scholar
• van Horssen J, van Schaik P, Witte M. Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders? Neurosci Lett. 2019;710:132931. doi:10.1016/j.neulet.2017.06.050
   PubMed Web of Science ®Google Scholar
• Volonté C, Amadio S, Cavaliere F, D’Ambrosi N, Vacca F, Bernardi G. Extracellular ATP and neurodegeneration. Curr Drug Targets CNS Neurol Disord. 2003;2(6):403–412. doi:10.2174/1568007033482643
   PubMedGoogle Scholar
• Xu P, Xu Y, Hu B, et al. Extracellular ATP enhances radiation-induced brain injury through microglial activation and paracrine signaling via P2X7 receptor. Brain Behav Immun. 2015;50:87–100. doi:10.1016/j.bbi.2015.06.020
   PubMed Web of Science ®Google Scholar
• Stenberg E, Thorell A. Insulin resistance in bariatric surgery. Curr Opin Clin Nutr Metab Care. 2020;23(4):255–261. doi:10.1097/MCO.0000000000000657
   PubMed Web of Science ®Google Scholar
• Mingrone G, Cummings DE. Changes of insulin sensitivity and secretion after bariatric/metabolic surgery. Surg Obes Relat Dis. 2016;12(6):1199–1205. doi:10.1016/j.soard.2016.05.013
   PubMed Web of Science ®Google Scholar
• Athauda D, Foltynie T. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson’s disease: mechanisms of action. Drug Discov Today. 2016;21(5):802–818. doi:10.1016/j.drudis.2016.01.013
   PubMed Web of Science ®Google Scholar
• Anandhakrishnan A, Korbonits M. Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity. World J Diabetes. 2016;7(20):572–598. doi:10.4239/wjd.v7.i20.572
   PubMed Web of Science ®Google Scholar
• During MJ, Cao L, Zuzga DS, et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med. 2003;9(9):1173–1179. doi:10.1038/nm919
   PubMed Web of Science ®Google Scholar
• Martinez JL, Derrick BE. Long-term potentiation and learning. Annu Rev Psychol. 1996;47(1):173–203. doi:10.1146/annurev.psych.47.1.173
   PubMedGoogle Scholar
• Robinson A, Lubitz I, Atrakchi-Baranes D, et al. Combination of insulin with a GLP1 agonist is associated with better memory and normal expression of insulin receptor pathway genes in a mouse model of Alzheimer’s disease. J Mol Neurosci. 2019;67(4):504–510. doi:10.1007/s12031-019-1257-9
   PubMed Web of Science ®Google Scholar
• Iwai T, Ito S, Tanimitsu K, Udagawa S, Oka J. Glucagon-like peptide-1 inhibits LPS-induced IL-1beta production in cultured rat astrocytes. Neurosci Res. 2006;55(4):352–360. doi:10.1016/j.neures.2006.04.008
   PubMed Web of Science ®Google Scholar
• Challa TD, Beaton N, Arnold M, Rudofsky G, Langhans W, Wolfrum C. Regulation of adipocyte formation by GLP-1/GLP-1R signaling. J Biol Chem. 2012;287(9):6421–6430. doi:10.1074/jbc.M111.310342
   PubMed Web of Science ®Google Scholar
• Bendotti G, Montefusco L, Lunati ME, et al. The anti-inflammatory and immunological properties of GLP-1 receptor agonists. Pharmacol Res. 2022;182:106320. doi:10.1016/j.phrs.2022.106320
   PubMed Web of Science ®Google Scholar
• Dirksen C, Jørgensen NB, Bojsen-Møller KN, et al. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int J Obes. 2013;37(11):1452–1459. doi:10.1038/ijo.2013.15
   PubMed Web of Science ®Google Scholar
• Stadlbauer U, Woods SC, Langhans W, Meyer U. PYY3-36: beyond food intake. Front Neuroendocrinol. 2015;38:1–11. doi:10.1016/j.yfrne.2014.12.003
   PubMed Web of Science ®Google Scholar
• Larraufie P, Martin-Gallausiaux C, Lapaque N, et al. SCFAs strongly stimulate PYY production in human enteroendocrine cells. Sci Rep. 2018;8(1):74. doi:10.1038/s41598-017-18259-0
   PubMedGoogle Scholar
• Liu BN, Liu XT, Liang ZH, Wang JH. Gut microbiota in obesity. World J Gastroenterol. 2021;27(25):3837–3850. doi:10.3748/wjg.v27.i25.3837
   PubMed Web of Science ®Google Scholar
• Batterham RL, Ffytche DH, Rosenthal JM, et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature. 2007;450(7166):106–109. doi:10.1038/nature06212
   PubMed Web of Science ®Google Scholar
• De Silva A, Salem V, Long CJ, et al. The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab. 2011;14(5):700–706. doi:10.1016/j.cmet.2011.09.010
   PubMed Web of Science ®Google Scholar
• Stadlbauer U, Arnold M, Weber E, Langhans W. Possible mechanisms of circulating PYY-induced satiation in male rats. Endocrinology. 2013;154(1):193–204. doi:10.1210/en.2012-1956
   PubMed Web of Science ®Google Scholar
• Stadlbauer U, Weber E, Langhans W, Meyer U. The Y2 receptor agonist PYY(3-36) increases the behavioural response to novelty and acute dopaminergic drug challenge in mice. Int J Neuropsychopharmacol. 2014;17(3):407–419. doi:10.1017/S1461145713001223
   PubMed Web of Science ®Google Scholar
• Stadlbauer U, Langhans W, Meyer U. Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia. Neuropsychopharmacology. 2013;38(12):2446–2455. doi:10.1038/npp.2013.146
   PubMed Web of Science ®Google Scholar
• Yamada C, Mogami S, Kanno H, Hattori T. Peptide YY causes apathy-like behavior via the dopamine D2 receptor in repeated water-immersed mice. Mol Neurobiol. 2018;55(9):7555–7566. doi:10.1007/s12035-018-0931-1
   PubMed Web of Science ®Google Scholar
• Larraufie P, Doré J, Lapaque N, Blottière HM. TLR ligands and butyrate increase Pyy expression through two distinct but inter-regulated pathways. Cell Microbiol. 2017;19(2):e12648. doi:10.1111/cmi.12648
   Web of Science ®Google Scholar
• Olsthoorn L, Vreeken D, Kiliaan AJ. Gut microbiome, inflammation, and cerebrovascular function: link between obesity and cognition. Front Neurosci Switz. 2021;15. doi:10.3389/fnins.2021.761456
   PubMed Web of Science ®Google Scholar
• Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol. 2020;11:25. doi:10.3389/fendo.2020.00025
   PubMed Web of Science ®Google Scholar
• Kim KN, Yao Y, Ju SY. Short Chain fatty acids and fecal microbiota abundance in humans with obesity: a systematic review and meta-analysis. Nutrients. 2019;11(10):2512. doi:10.3390/nu11102512
   PubMed Web of Science ®Google Scholar
• Evrensel A, Ünsalver B, Ceylan ME. Neuroinflammation, gut-brain axis and depression. Psychiatry Investig. 2020;17(1):2–8. doi:10.30773/pi.2019.08.09
   PubMed Web of Science ®Google Scholar
• Marotta A, Sarno E, Del Casale A, et al. Effects of Probiotics on cognitive reactivity, mood, and sleep quality. Front Psychiatry. 2019;10:10. doi:10.3389/fpsyt.2019.00010
   PubMed Web of Science ®Google Scholar
• Vinolo MAR, Rodrigues HG, Nachbar RT, Curi R. Regulation of Inflammation by short chain fatty acids. Nutrients. 2011;3(10):858–876. doi:10.3390/nu3100858
   PubMed Web of Science ®Google Scholar
• Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504(7480):451–455. doi:10.1038/nature12726
   PubMed Web of Science ®Google Scholar
• Salvi PS, Cowles RA. Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells. 2021;10(7):1775. doi:10.3390/cells10071775
   PubMed Web of Science ®Google Scholar
• Yang R, Hu X, Xie X, et al. Propionic acid targets the TLR4/NF-κB signaling pathway and inhibits LPS-induced intestinal barrier dysfunction: in vitro and in vivo studies. Front Pharmacol. 2020;11:573475. doi:10.3389/fphar.2020.573475
   PubMed Web of Science ®Google Scholar
• Caesar R, Tremaroli V, Kovatcheva-Datchary P, Cani PD, Bäckhed F. Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab. 2015;22(4):658–668. doi:10.1016/j.cmet.2015.07.026
   PubMed Web of Science ®Google Scholar
• Vaure C, Liu Y. A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol. 2014;5:316. doi:10.3389/fimmu.2014.00316
   PubMed Web of Science ®Google Scholar
• Han C, Ding Z, Shi H, Qian W, Hou X, Lin R. The role of probiotics in lipopolysaccharide-induced autophagy in intestinal epithelial cells. Cell Physiol Biochem. 2016;38(6):2464–2478. doi:10.1159/000445597
   PubMed Web of Science ®Google Scholar
• Sánchez-Alcoholado L, Gutiérrez-Repiso C, Gómez-Pérez AM, García-Fuentes E, Tinahones FJ, Moreno-Indias I. Gut microbiota adaptation after weight loss by Roux-en-Y gastric bypass or sleeve gastrectomy bariatric surgeries. Surg Obes Relat Dis. 2019;15(11):1888–1895. doi:10.1016/j.soard.2019.08.551
   PubMed Web of Science ®Google Scholar
• Magouliotis DE, Tasiopoulou VS, Sioka E, Chatedaki C, Zacharoulis D. Impact of bariatric surgery on metabolic and gut microbiota profile: a systematic review and meta-analysis. Obes Surg. 2017;27(5):1345–1357. doi:10.1007/s11695-017-2595-8
   PubMed Web of Science ®Google Scholar
• de Vos WM. Microbe Profile: akkermansia muciniphila: a conserved intestinal symbiont that acts as the gatekeeper of our mucosa. Microbiology. 2017;163(5):646–648. doi:10.1099/mic.0.000444
   PubMed Web of Science ®Google Scholar
• Debedat J, Clement K, Aron-Wisnewsky J. Gut microbiota dysbiosis in human obesity: impact of bariatric surgery. Curr Obes Rep. 2019;8(3):229–242. doi:10.1007/s13679-019-00351-3
   PubMed Web of Science ®Google Scholar
• Farup PG, Valeur J. Changes in faecal short-chain fatty acids after weight-loss interventions in subjects with morbid obesity. Nutrients. 2020;12(3):802. doi:10.3390/nu12030802
   PubMed Web of Science ®Google Scholar
• Cypess AM, Ingelfinger JR. Reassessing human adipose tissue. N Engl J Med. 2022;386(8):768–779. doi:10.1056/NEJMra2032804
   PubMed Web of Science ®Google Scholar
• Kahn CR, Wang G, Lee KY. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J Clin Invest. 2019;129(10):3990–4000. doi:10.1172/JCI129187
   PubMed Web of Science ®Google Scholar
• Rabiee A. Beige fat maintenance; toward a sustained metabolic health. Front Endocrinol. 2020;11:634. doi:10.3389/fendo.2020.00634
   PubMed Web of Science ®Google Scholar
• Kiliaan AJ, Arnoldussen IA, Gustafson DR. Adipokines: a link between obesity and dementia? Lancet Neurol. 2014;13(9):913–923. doi:10.1016/S1474-4422(14)70085-7
   PubMed Web of Science ®Google Scholar
• Sturm W, Sandhofer A, Engl J, et al. Influence of visceral obesity and liver fat on vascular structure and function in obese subjects. Obesity. 2009;17(9):1783–1788. doi:10.1038/oby.2009.81
   PubMed Web of Science ®Google Scholar
• Arnoldussen IAC, Kiliaan AJ, Gustafson DR. Obesity and dementia: adipokines interact with the brain. Eur. Neuropsychopharmacol. 2014;24(12):1982–1999. doi:10.1016/j.euroneuro.2014.03.002
   PubMed Web of Science ®Google Scholar
• Balasubramanian B, Kim HJ, Mothana RA, Kim YO, Siddiqui NA. Role of LXR alpha in regulating expression of glucose transporter 4 in adipocytes - Investigation on improvement of health of diabetic patients. J Infect Public Health. 2020;13(2):244–252. doi:10.1016/j.jiph.2019.09.008
   PubMed Web of Science ®Google Scholar
• Perry RJ, Camporez JG, Kursawe R, et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015;160(4):745–758. doi:10.1016/j.cell.2015.01.012
   PubMed Web of Science ®Google Scholar
• Miller AA, Spencer SJ. Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav Immun. 2014;42:10–21.
   PubMed Web of Science ®Google Scholar
• Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol. 2012;8(9):544–556. doi:10.1038/nrendo.2012.48
   PubMed Web of Science ®Google Scholar
• Ma IT, Madura JA. Gastrointestinal complications after bariatric surgery. Gastroenterol Hepatol. 2015;11(8):526–535.
   Google Scholar